U.S., May 27 -- ClinicalTrials.gov registry received information related to the study (NCT07607496) titled 'MacuTherm Performance Study in Patients With iAMD' on May 13.
Brief Summary: The goal of this study is to demonstrate that photothermal therapy with the individually dosed treatment plan proposed by Macula Explorer delivered safely by Navilas(R) Laser System effectively improves the life of photoreceptors and reduces the progression of intermediate Age-related Macular Degeneration (iAMD) and preserves photoreceptors shown by Ellipsoid Zone Integrity (EZI).
Participants will be randomized to either Treatment or Control Group. There will be 12 visits, monthly for the first 3 months, then quarterly until the end of the study after 2 ye...